Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance
The Poly (ADP-ribose) polymerase (PARP) family has many essential functions in cellular
processes, including the regulation of transcription, apoptosis and the DNA damage …
processes, including the regulation of transcription, apoptosis and the DNA damage …
Health and racial disparity in breast cancer
CG Yedjou, JN Sims, L Miele, F Noubissi… - … cancer metastasis and …, 2019 - Springer
Breast cancer is the most common noncutaneous malignancy and the second most lethal
form of cancer among women in the United States. It currently affects more than one in ten …
form of cancer among women in the United States. It currently affects more than one in ten …
Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology
MB Daly, T Pal, MP Berry, SS Buys, P Dickson… - Journal of the National …, 2021 - jnccn.org
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and
Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants …
Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants …
Breast cancer risk genes—association analysis in more than 113,000 women
Breast Cancer Association … - New England Journal of …, 2021 - Mass Medical Soc
Background Genetic testing for breast cancer susceptibility is widely used, but for many
genes, evidence of an association with breast cancer is weak, underlying risk estimates are …
genes, evidence of an association with breast cancer is weak, underlying risk estimates are …
An organoid platform for ovarian cancer captures intra-and interpatient heterogeneity
O Kopper, CJ De Witte, K Lõhmussaar… - Nature medicine, 2019 - nature.com
Ovarian cancer (OC) is a heterogeneous disease usually diagnosed at a late stage.
Experimental in vitro models that faithfully capture the hallmarks and tumor heterogeneity of …
Experimental in vitro models that faithfully capture the hallmarks and tumor heterogeneity of …
The personal and clinical utility of polygenic risk scores
Initial expectations for genome-wide association studies were high, as such studies
promised to rapidly transform personalized medicine with individualized disease risk …
promised to rapidly transform personalized medicine with individualized disease risk …
Breastfeeding reduces the risk of breast cancer: A call for action in high‐income countries with low rates of breastfeeding
B Stordal - Cancer medicine, 2023 - Wiley Online Library
Women in the UK have a 15% lifetime risk of develo** breast cancer. Like other high‐
income countries, women in the UK are having children later in life which increases their …
income countries, women in the UK are having children later in life which increases their …
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Genetic variation can predispose to disease both through (i) monogenic risk variants that
disrupt a physiologic pathway with large effect on disease and (ii) polygenic risk that …
disrupt a physiologic pathway with large effect on disease and (ii) polygenic risk that …
Incomplete penetrance and variable expressivity: from clinical studies to population cohorts
R Kingdom, CF Wright - Frontiers in Genetics, 2022 - frontiersin.org
The same genetic variant found in different individuals can cause a range of diverse
phenotypes, from no discernible clinical phenotype to severe disease, even among related …
phenotypes, from no discernible clinical phenotype to severe disease, even among related …
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
X Yang, G Leslie, A Doroszuk, S Schneider… - Journal of clinical …, 2020 - ascopubs.org
PURPOSE To estimate age-specific relative and absolute cancer risks of breast cancer and
to estimate risks of ovarian, pancreatic, male breast, prostate, and colorectal cancers …
to estimate risks of ovarian, pancreatic, male breast, prostate, and colorectal cancers …